Skip to main content
. 2020 Nov 10;10(11):1536. doi: 10.3390/biom10111536

Table 1.

Current available treatments for prostate cancer.

Treatment Target Risks and Recurrence
Prostatectomy Efficient against localized and early- or advanced-stage tumors [13] Moderate biochemical recurrence rate in localized tumors, risk of spreading beyond original location [22]
Androgen deprivation therapy Efficient against androgen- dependent carcinomas Androgen insensitivity may develop leading to reoccurrence [23]
Radiation therapy Efficient against localized tumors or minimally metastasized tumors [15] Low efficacy if tumor has developed beyond early stages, requiring combination treatments; higher mortality compared to prostatectomy
[24,25]
Chemotherapy Primarily utilized to treat advanced-stage, metastatic, castration-resistant prostate cancer
[26]
Improves quality of life and slows disease progression in high-risk prostate cancer, but unlikely to cure it [27,28]